Abstract:Many intensive care unit (ICU) patients do not achieve target protein intakes particularly in the early days following admittance. This period of iatrogenic protein undernutrition contributes to a rapid loss of lean, in particular muscle, mass in the ICU. The loss of muscle in older (aged >60 years) patients in the ICU may be particularly rapid due to a perfect storm of increased catabolic factors, including systemic inflammation, disuse, protein malnutrition, and reduced anabolic stimuli. This loss of muscle … Show more
“…For adult patients in intensive care units (ICU), complete PN mixtures with a high protein/energy ratio would be recommended [32,33]. Unfortunately, most all-in-one industrialized mixtures generally do not guarantee sufficient AA supply to restore nitrogen losses [22,[34][35][36][37]. In these selected cases, personalized all-in-one PN mixtures represent the best solution to satisfy patient needs and prevent possible complications (i.e., overfeeding or refeeding in case of over-calorie supply).…”
The right amount and quality of amino acids (AAs) supplied to patients on parenteral nutrition (PN) reduces muscle mass loss, may preserve or even increase it, with significant clinical benefits. Several industrial PN mixtures are available so that nutrition specialists can choose the product closest to the patient’s needs. In selected cases, there is the possibility of personalizing compounded mixtures in a hospital pharmacy that completely meets the individual nutritional needs of PN patients. This narrative review deals with the AA solutions used in PN mixtures. The physiology, the methods to calculate the AA needs, and the AA and energy requirements suggested by scientific guidelines for each patient type are also reported.
“…For adult patients in intensive care units (ICU), complete PN mixtures with a high protein/energy ratio would be recommended [32,33]. Unfortunately, most all-in-one industrialized mixtures generally do not guarantee sufficient AA supply to restore nitrogen losses [22,[34][35][36][37]. In these selected cases, personalized all-in-one PN mixtures represent the best solution to satisfy patient needs and prevent possible complications (i.e., overfeeding or refeeding in case of over-calorie supply).…”
The right amount and quality of amino acids (AAs) supplied to patients on parenteral nutrition (PN) reduces muscle mass loss, may preserve or even increase it, with significant clinical benefits. Several industrial PN mixtures are available so that nutrition specialists can choose the product closest to the patient’s needs. In selected cases, there is the possibility of personalizing compounded mixtures in a hospital pharmacy that completely meets the individual nutritional needs of PN patients. This narrative review deals with the AA solutions used in PN mixtures. The physiology, the methods to calculate the AA needs, and the AA and energy requirements suggested by scientific guidelines for each patient type are also reported.
“…32 Isolated EAA such as leucine and its downstream metabolite, β-hydroxy β-methylbutyrate (HMB), have also been used in experimental models of SMM loss (i.e., bed rest/ casting) 21 due to their ability to stimulate MPS 38 and replete the increasing need in muscle protein metabolism observed in states of ageing, inactivity and disease. 16,39 This short, narrative review provides an overview of the latest evidence, with an emphasis on randomised controlled trials known to the authors and available on PubMed, related to the effects of protein supplementation on SMM, strength and function in individuals at risk of muscle wasting disorders, including those residing in long-term care facilities, admitted to hospital, and other clinical populations such as those with chronic obstructive pulmonary disease, heart disease, type 2 diabetes or cancer.…”
Section: Practice Impactmentioning
confidence: 99%
“…14 A hallmark of these states are reduced levels of physical activity or in some cases complete muscle disuse due to illness, surgery or immobilisation. 15,16 Indeed, it has been documented that older adults residing in residential aged care facilities spend approximately 12.5 hours per day sitting or lying, 17 and hospitalised patients may spend about 17 hours a day bed-ridden, 18 which markedly increases the risk of SMM loss. In community-dwelling older adults, 14 days of reduced physical activity in the form of a reduction in the number of steps performed daily (from 5962 ± 695 to 1413 ± 110 steps per day) resulted in a 2.8% loss of leg lean mass.…”
Section: Introductionmentioning
confidence: 99%
“…28 This is particularly concerning as in addition to the low levels of physical activity in nursing home residents and hospitalised patients, these individuals often have acute and chronic illnesses which accelerates the loss of SMM due, in part, to a pro-inflammatory status which favours muscle protein catabolism. 16 To prevent or attenuate SMM loss, a positive protein balance must be achieved. That is, muscle protein synthesis must exceed muscle protein breakdown rates over a daily cycle to promote muscle protein accretion.…”
To examine the effects of protein supplementation on muscle mass, strength and function in individuals at risk of muscle wasting disorders. Methods: A narrative overview of the literature based on a PubMed search. Results: Increasing protein intake beyond the recommended dietary intake may prevent or attenuate muscle loss in people at risk of muscle wasting disorders; however, there is inconsistent evidence for any benefits on muscle strength or physical function. This is likely due to the significant heterogeneity and bias regarding baseline demographics, basal protein/energy intakes and protein supplement type, dose, timing and compliance. Conclusion: Protein supplementation attenuates muscle loss in some populations at increased risk of muscle wasting, but there is no consistent evidence to support benefits on muscle strength or physical function. Further randomised controlled trials are needed that focus on whether there is an optimal type, dose and timing of protein intake, and potential interaction with other nutrients.
“…However, for older adults, the WHO had recommended 0.8 g/kg/d since 1985 4 . While the nitrogen balance data that were used for this recommendation indicated higher protein requirements, 5 only recently has expert consensus suggested that protein recommendations for older adults should be higher: 1.0–1.2 g/kg when healthy and up to 1.2–1.5 g/kg when combined with acute disorders, chronic disease, or physical training 7 – 9 …”
Section: Definition Of Protein Requirements and Application To Intensmentioning
Insight into protein requirements of intensive care unit (ICU) patients is urgently needed, but at present, it is unrealistic to define protein requirements for different diagnostic groups of critical illness or at different stages of illness. No large randomized controlled trials have randomized protein delivery, adequately addressed energy intake, and evaluated relevant clinical outcomes. As a pragmatic approach, experimental studies have focused on protein requirements of heterogeneous ICU patients. Data are scarce and the absolute value of protein requirements therefore is an approximation. Experimental studies indicate a protein requirement of >1.2 g/kg protein, which is supported by several outcome-based observational studies. Protein intake levels of up to 2.0-2.5 g/kg appear to be safe. A higher level of personalized treatment, within 1.2 and 2.5 g/kg, must involve identification of patients with low muscle protein mass that might benefit most from adequate protein nutrition in the ICU.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.